Lipocine (NASDAQ:LPCN) is a specialty pharmaceutical company that has an oral drug delivery technology for products that affect men's and women's health. The technology is designed to improve patient compliance and safety through orally available products, while at the same time increasing the bioavailability of drugs that are poorly absorbed through oral administration and do not reach a sufficient threshold in the circulation.
The company is currently developing three product candidates that are designed to enhance the pharmacokinetic parameters of the drugs, facilitate lower dosing requirements, reduce side effects, and limit gastrointestinal interactions that would otherwise decrease the effectiveness of the compounds.
Below we provide an overview of the two therapeutic areas that Lipocine is focused on, testosterone
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|